CO4920213A1 - Forma en microparticulasw del clorhidrato de 1 2 2naftil etil 4 3trifluorometilfenil 1 2 3 6 tetrahidropiridina - Google Patents
Forma en microparticulasw del clorhidrato de 1 2 2naftil etil 4 3trifluorometilfenil 1 2 3 6 tetrahidropiridinaInfo
- Publication number
- CO4920213A1 CO4920213A1 CO97074790A CO97074790A CO4920213A1 CO 4920213 A1 CO4920213 A1 CO 4920213A1 CO 97074790 A CO97074790 A CO 97074790A CO 97074790 A CO97074790 A CO 97074790A CO 4920213 A1 CO4920213 A1 CO 4920213A1
- Authority
- CO
- Colombia
- Prior art keywords
- trifluorometilfenil
- tetrahidropiridina
- microparticulas
- naftil
- etil
- Prior art date
Links
- ZITFWUUYPONCCK-UHFFFAOYSA-N 1,2,3,4,5,6-hexachlorocyclohexane;naphthalen-1-yl n-methylcarbamate Chemical compound ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl.C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 ZITFWUUYPONCCK-UHFFFAOYSA-N 0.000 title 1
- 239000011859 microparticle Substances 0.000 abstract 2
- WVHBEIJGAINUBW-UHFFFAOYSA-N Xaliproden hydrochloride Chemical compound Cl.FC(F)(F)C1=CC=CC(C=2CCN(CCC=3C=C4C=CC=CC4=CC=3)CC=2)=C1 WVHBEIJGAINUBW-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9615905A FR2757510B1 (fr) | 1996-12-23 | 1996-12-23 | Forme microparticulaire d'un derive de tetrahydropyridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4920213A1 true CO4920213A1 (es) | 2000-05-29 |
Family
ID=9499044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97074790A CO4920213A1 (es) | 1996-12-23 | 1997-12-23 | Forma en microparticulasw del clorhidrato de 1 2 2naftil etil 4 3trifluorometilfenil 1 2 3 6 tetrahidropiridina |
Country Status (37)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100579514C (zh) * | 2001-07-06 | 2010-01-13 | 生命周期药物公司 | 通过受控制的凝聚而制备颗粒物的方法以及提高生物利用度的方法 |
| BE1015641A4 (fr) * | 2003-05-26 | 2005-07-05 | Mariani Jean Paul | Micronisation 70. |
| RU2472490C1 (ru) * | 2011-08-05 | 2013-01-20 | Открытое акционерное общество "Биосинтез" | Средство для лечения кожных гнойных инфекций, составы и способы получения |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US562883A (en) * | 1896-06-30 | Thill-coupling | ||
| FR2531707A1 (fr) * | 1982-08-16 | 1984-02-17 | Midy Spa | Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques |
| US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
| FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| FR2639226B1 (fr) * | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
| FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
| WO1994009898A1 (de) * | 1992-10-26 | 1994-05-11 | Schwarz Pharma Ag | Verfahren zur herstellung von mikrokapseln |
| US5560932A (en) * | 1995-01-10 | 1996-10-01 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents |
| US5662883A (en) * | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
| US6489334B2 (en) * | 1996-12-23 | 2002-12-03 | Sanofi-Synthelabo | Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms |
| FR2763847B1 (fr) * | 1997-05-28 | 2003-06-06 | Sanofi Sa | Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1 |
| US20020147216A1 (en) * | 2000-01-31 | 2002-10-10 | Yuhong Zhou | Mucin synthesis inhibitors |
-
1996
- 1996-12-23 FR FR9615905A patent/FR2757510B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-19 AR ARP970106030A patent/AR009673A1/es not_active Application Discontinuation
- 1997-12-22 MY MYPI97006232A patent/MY126298A/en unknown
- 1997-12-22 DZ DZ970236A patent/DZ2386A1/xx active
- 1997-12-23 DE DE69724999T patent/DE69724999T2/de not_active Expired - Lifetime
- 1997-12-23 NZ NZ336129A patent/NZ336129A/xx not_active IP Right Cessation
- 1997-12-23 CN CN97180862A patent/CN1088698C/zh not_active Expired - Fee Related
- 1997-12-23 JP JP52848298A patent/JP4422214B2/ja not_active Expired - Fee Related
- 1997-12-23 EG EG138497A patent/EG24749A/xx active
- 1997-12-23 IL IL12993797A patent/IL129937A/en not_active IP Right Cessation
- 1997-12-23 PT PT97952987T patent/PT950051E/pt unknown
- 1997-12-23 US US09/331,514 patent/US20020028247A1/en not_active Abandoned
- 1997-12-23 EE EEP199900263A patent/EE04112B1/xx not_active IP Right Cessation
- 1997-12-23 AU AU56685/98A patent/AU730302B2/en not_active Ceased
- 1997-12-23 ES ES97952987T patent/ES2207758T3/es not_active Expired - Lifetime
- 1997-12-23 WO PCT/FR1997/002394 patent/WO1998028272A1/fr active IP Right Grant
- 1997-12-23 KR KR10-1999-7005372A patent/KR100455797B1/ko not_active Expired - Fee Related
- 1997-12-23 EP EP97952987A patent/EP0950051B1/fr not_active Expired - Lifetime
- 1997-12-23 UA UA99063520A patent/UA66776C2/uk unknown
- 1997-12-23 CA CA002275593A patent/CA2275593C/en not_active Expired - Fee Related
- 1997-12-23 AT AT97952987T patent/ATE250032T1/de active
- 1997-12-23 TR TR1999/01362T patent/TR199901362T2/xx unknown
- 1997-12-23 SI SI9730592T patent/SI0950051T1/xx unknown
- 1997-12-23 RU RU99116321/04A patent/RU2193031C2/ru not_active IP Right Cessation
- 1997-12-23 YU YU28899A patent/YU49427B/sh unknown
- 1997-12-23 CZ CZ19992291A patent/CZ294272B6/cs not_active IP Right Cessation
- 1997-12-23 PL PL97334276A patent/PL190098B1/pl not_active IP Right Cessation
- 1997-12-23 CO CO97074790A patent/CO4920213A1/es unknown
- 1997-12-23 SK SK829-99A patent/SK283917B6/sk not_active IP Right Cessation
- 1997-12-23 IN IN3767DE1997 patent/IN186977B/en unknown
- 1997-12-23 BR BR9714177-1A patent/BR9714177A/pt not_active Application Discontinuation
- 1997-12-23 DK DK97952987T patent/DK0950051T3/da active
- 1997-12-23 ZA ZA9711579A patent/ZA9711579B/xx unknown
- 1997-12-23 HU HU0001181A patent/HU224348B1/hu not_active IP Right Cessation
-
1998
- 1998-01-21 TW TW086119619A patent/TW534820B/zh not_active IP Right Cessation
-
1999
- 1999-06-10 IS IS5077A patent/IS2064B/xx unknown
- 1999-06-22 NO NO19993077A patent/NO311569B1/no not_active IP Right Cessation
-
2002
- 2002-06-21 US US10/177,384 patent/US20020192292A1/en not_active Abandoned
-
2008
- 2008-06-13 US US12/138,582 patent/US20080255365A1/en not_active Abandoned
-
2009
- 2009-06-10 JP JP2009139083A patent/JP2009280581A/ja active Pending
- 2009-10-05 US US12/573,455 patent/US20100021541A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR018197A1 (es) | Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento | |
| BG106030A (en) | Pharmaceutical composition | |
| BR9902268A (pt) | Formulações de ziprasidona. | |
| AR032132A1 (es) | Composicion farmaceutica que comprende una combinacion de un compuesto de tramadol y una droga anticonvulsiva y uso de la combinacion para preparar un medicamento | |
| BR9911724A (pt) | Ciclosporina que tem um perfil de atividade melhorado | |
| AR033466A1 (es) | Composicion farmaceutica estabilizada para administracion oral | |
| TR200100931T2 (tr) | Yeni sürekli salınımlı oral formülasyonlar | |
| IL133397A (en) | Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin | |
| ATE495154T1 (de) | Pharmazeutische zusammensetzungen, die ccr5- antagonisierende piperazinderivate enthalten | |
| ES2171416T3 (es) | Remedio contra la trombocitopenia. | |
| ATE381533T1 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
| DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| CO4920213A1 (es) | Forma en microparticulasw del clorhidrato de 1 2 2naftil etil 4 3trifluorometilfenil 1 2 3 6 tetrahidropiridina | |
| EP1457212A4 (en) | OPHTHALMIC DROPS | |
| ES2150404T3 (es) | Composiciones farmaceuticas de tizoxanida y nitozoxanida. | |
| ATE309788T1 (de) | Mikropartikel mit verbessertem freisetzungsprofil und verfahren zu deren herstellung | |
| UY25247A1 (es) | Asociacion de principios activos para el tratamiento de la demencia senil de tipo alzheimer | |
| ATE342734T1 (de) | Adenosin a1 antagonisten gegen männliche sterilität | |
| ES2191908T3 (es) | 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido. | |
| BR9802803A (pt) | ação e composições farmacêuticas contendo os mesmos. | |
| ATE282416T1 (de) | Die verwendung von nk-1 rezeptor antagonisten für die behandlung von substanz-verwendung störungen | |
| GT199800009A (es) | Forma en microparticulas del clorhidrato de 1-[2-(2-naftil)etil]-4-(3-trifluoro-metilfenil)-1,2,3,6-tetrahidropiridina. | |
| DE69732492D1 (de) | Verwendung von nk-1 rezeptorantagonisten zur behandlung von schweren depressionen, die von angstzuständen begleitet werden | |
| ATE373475T1 (de) | Carbamate von 2-heterozyklischen 1,2-ethandiolen | |
| AR018825A1 (es) | Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas |